Comparing Nukkleus (DFNS) & The Competition

Nukkleus (NASDAQ:DFNS) is one of 229 publicly-traded companies in the “Aerospace & Defense” industry, but how does it weigh in compared to its rivals? We will compare Nukkleus to similar companies based on the strength of its profitability, earnings, valuation, dividends, institutional ownership, risk and analyst recommendations.

Volatility and Risk

Nukkleus has a beta of -6, meaning that its share price is 700% less volatile than the S&P 500. Comparatively, Nukkleus’ rivals have a beta of 1.31, meaning that their average share price is 31% more volatile than the S&P 500.

Earnings & Valuation

This table compares Nukkleus and its rivals gross revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Nukkleus	$5.91 million	$78.55 million	-0.00
Nukkleus Competitors	$8.34 billion	$569.54 million	25.80

Nukkleus’ rivals have higher revenue and earnings than Nukkleus. Nukkleus is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.

Insider & Institutional Ownership

12.5% of Nukkleus shares are owned by institutional investors. Comparatively, 49.5% of shares of all “Aerospace & Defense” companies are owned by institutional investors. 11.1% of Nukkleus shares are owned by insiders. Comparatively, 11.8% of shares of all “Aerospace & Defense” companies are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Profitability

This table compares Nukkleus and its rivals’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Nukkleus	N/A	N/A	-26.92%
Nukkleus Competitors	-278.19%	-46.46%	-4.02%

Analyst Ratings

This is a summary of recent ratings and recommmendations for Nukkleus and its rivals, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nukkleus	1	0	0	1	2.50
Nukkleus Competitors	2156	8263	12769	580	2.50

As a group, “Aerospace & Defense” companies have a potential upside of 27.55%. Given Nukkleus’ rivals higher possible upside, analysts plainly believe Nukkleus has less favorable growth aspects than its rivals.

Summary

Nukkleus rivals beat Nukkleus on 8 of the 12 factors compared.

About Nukkleus

Nukkleus Inc., a financial technology company, provides blockchain-enabled technology solutions worldwide. It focuses on providing software and technology solutions for retail foreign exchange trading industry. The company provides transactions platform for dealing and risk management services. It also offers cross-border payment and transactions solutions and blockchain-enabled financial services solutions to institutional investors. In addition, the company provides software, technology, customer sales and marketing, and risk management technology hardware and software solutions. Nukkleus Inc. was founded in 2013 and is headquartered in Jersey City, New Jersey.